RACHEL KLOSKI: Open Payments
NPI 1558149070 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 50 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $335 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $434 |
| Novo Nordisk Inc | 5 | $108 |
| ABBVIE INC. | 3 | $54 |
| Amgen Inc. | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Verona Pharma, Inc. | 2 | $29 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
Products named: CAPLYTA, Wegovy, VRAYLAR, DUPIXENT, INSPIRE, TRELEGY ELLIPTA, Ohtuvayre, TZIELD.
Industry payments across MI — which companies pay providers there.
